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Thyroid hormone increases the Ca2+-ATPase activity of the sarcoplasmic reticulum (SR) in
skeletal muscle, thereby increasing the energy-turnover associated with Ca2+-cycling during
contraction and rest. The fast-muscle isoform of the Ca2+-ATPase (SERCA1) and the slow-
muscle isoform (SERCA2a), are encoded by two genes that are transcriptionally regulated
by T3 . The SERCA1 isoform can be expressed to considerably higher levels than the
SERCA2a isoform. The stimulation of transcription of the SERCA1 gene by T3 is mediated
by two thyroid hormone response elements, located in the promoter of this gene. The
intracellular [Ca2+] can modulate the effect of T3 . The increase in SR Ca
2+-ATPase activity
seen when T3-levels rise above normal, results from the induction of SERCA1 expression
in slow muscle fibers. Concomitant high levels of Ca2+-ATPase activity are associated with
down-regulation of SERCA2a expression in these fibers. The observed T3-dependent
increase in SERCA1 expression and associated Ca2+-ATPase activity will increase the over-
all metabolic rate of the organism significantly under normal conditions, because of the
high average level of contractile activity of slow fibers. Given the rise in serum T3-levels
during prolonged cold exposure, these data suggest that fiber-specific stimulation of
SERCA1 expression contributes to the thermogenic response in non-shivering thermogen-
esis. This mechanism may be particularly relevant in larger mammals, which have a rela-
tively high percentage of slow fibers in skeletal muscle, and which need to rely on tissues
other than brown fat for the generation of extra heat.
KEY WORDS: SERCA1; SERCA2a; ATPase; calcium; sarcoplasmic reticulum; skeletal
muscle; thyroid hormone.
INTRODUCTION
The resting metabolic rate (RMR) is a function of the thyroid status and the general
stimulatory effect of thyroid hormone (T3) on metabolism of practically all tissues
is perhaps the best known action of this hormone. Equally important, however, is
that T3 enhances energy turnover during cellular activity. This is particularly true
during contraction of skeletal muscle, which is a principle target tissue of T3 . The
contribution of resting muscle metabolism to the RMR of mammals is estimated to
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be around 20% [1], but this percentage rises sharply with increasing activity of the
organism. This heat-generating capacity of contraction is used as a first line of
defense against hypothermia in the shivering response. During prolonged exposure
to the cold, shivering subsides and non-shivering thermogenesis (NST) takes over
with increased circulating levels of norepinephrine (NE) and T3 , resulting in a rise
in RMR. Small mammals, like the mouse and rat, have a relatively high rate of heat
loss, and at 4°C, the RMR needs to double to maintain body temperature. This
NST resides almost exclusively in brown adipose tissue (BAT) and is mediated by
the mitochondrial uncoupling protein UCP1 [2, 3]. T3 is merely permissive, yet essen-
tial, for the thermoregulatory action of NE on UCP1 activity. In fact, the rise in
serum T3 seen during cold exposure is secondary to the increase in NE and not
required for the effect on BAT [4, 5]. Although a rise in T3-levels will stimulate the
RMR in most tissues, this thermogenic effect is not important for successful cold
adaptation in mice or rats. However, it could come into play in larger animals,
which need to rely on tissues other than BAT for extra heat generation. Skeletal
muscle is thought to play a significant role in NST in larger animals, because of the
metabolic capacity and total mass of this tissue. Various mechanisms may contribute
to enhanced muscle metabolism, but several lines of evidence suggest increased
expression of the sarcoplasmic reticulum (SR) Ca2+-ATPase—and a concomitant
increase in Ca2+-cycling—as a principle source of extra heat generation [6–9]. This
points to a possible direct action of T3 in NST, rather than a permissive one, because
the expression of SR Ca2+-ATPase is stimulated by T3 . The focus of this report is
therefore on the regulation of the multiple Ca2+-ATPase genes by T3 in different
muscle fiber types. We will begin with a summary of the data which identified the
SR Ca2+-ATPase as a target in T3-dependent muscle metabolism, and we will then
focus on the mechanism of regulation of SR Ca2+-ATPase expression and the impli-
cations of this regulation for thermogenesis.
THYROID STATUS, Ca2C-HANDLING AND SKELETAL MUSCLE
FIBER TYPES
In general, the RMR in hypothyroid mammals is 70% of euthyroid (control)
values, whereas in hyperthyroidism this is 150% [10]. This is also found in rats and
the 2-fold stimulation of RMR by T3 mostly reflects effects on tissues other than
BAT, since this tissue is not activated in hyperthyroidism. Actually, UCP1
expression is suppressed in hyperthyroidism, possibly as a compensatory mechanism
for the increased heat production in other tissues (5). When studying the rat at
thermoneutrality the T3-dependent metabolism in the range between hypo- and
euthyroidism can be viewed as the contribution to obligatory thermogenesis,
whereas the range between eu- and hyperthyroidism indicates the capacity for energy
turnover in tissues other than BAT, which in principle could be mobilized by T3 in
NST. Serum levels of T3 in cold-adapted rats are in the range of mild to overt
hyperthyroidism, resulting from increased hormone production by the thyroid, but
primarily from a NE-dependent increase in peripheral conversion of T4 to T3 by
type II 5′-deiodinase [4, 5].
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A series of experiments using perfused hind limb of the rat provided the basis
for our work on T3-regulation of SR Ca
2+-ATPase (see Refs. 1, 10–12 for a more
detailed review of these data). The essence of these results was that the characteristic
2-fold difference between hypothyroid and hyperthyroid rats in resting O2-consump-
tion of the muscle preparation could be ascribed primarily to increased Ca2+-cycling
by the SR. The T3-dependent increase in SR Ca
2+-ATPase activity suggested by
these data was subsequently confirmed by determination of SR Ca2+-uptake activity,
coupled ATPase activity, and level of phosphorylated intermediate of the enzyme in
purified SR and muscle homogenates [13–18]. A 2-fold increase in muscle SR Ca2+-
ATPase activity from hypo- to euthyroidism was found for slow muscle and again
a doubling in the transition to hyperthyroidism, whereas in fast muscle T3 induced
a maximal 50% increase, with little effect in hyperthyroidism. Measurement of the
actual heat production associated with SR Ca2+-cycling during contraction corre-
lated quantitatively with the stimulation of Ca2+-ATPase activity by T3 in slow and
fast muscle [19]. These measurements also showed that SR Ca2+-cycling accounts for
20 to 50% of the heat produced during contraction. The effect on the SR activity in
both muscle types also provided a basis for the well known stimulation of the relax-
ation rate by T3 , which together with an enhanced contraction rate are classic symp-
toms in increased thyroid activity.
Since the effect of T3 is an increase in the speed of the contractile process it is
not surprising that the effects are more pronounced in slow muscle. The expression
of myosin heavy chain (MHC) isoforms with higher catalytic turnover rates was
already well established as the basis for the stimulation of the rate of contraction
[20, 21]. These isoforms are part of the phenotype that make up the different fiber
types present in skeletal muscle, which are furthermore characterized by their prin-
ciple pathway for generating ATP, i.e., oxidative for sustained activity and glycolytic
for short bursts of activity with high ATP turnover. The major isoforms of MHC
are MHC I, IIa and IIb, ranked in order of increasing catalytic turnover rate. There-
fore, MHC I is found in slow oxidative fibers (type I), MHC IIa in fast oxidative
glycolytic fibers (type IIA), which have intermediate contraction rates, and MHC
IIb in the fastest, glycolytic fibers (type IIB). Type IIC fibers contain a mixture of
MHC I and IIa, and MHC IIx is an intermediate isoform between IIa and IIb.
Under normal conditions the different fiber types are optimally geared to their task.
Type I fibers are the principle fiber in slow twitch, fatigue resistant muscles, used
for maintaining posture and relatively slow movement. These slow fibers are typi-
cally active 20–30% of the time at a low frequency (20 Hz) [22]. Fast fibers, on the
other hand, are active for only about 0.2% of the time, but at frequencies of up to
200 Hz [22], and fast-twitch muscles are composed of roughly equal amounts of type
IIA and IIB fibers, with small amounts of type I fibers mixed in [23]. The phenotype
which is expressed in a fiber is mainly determined by T3 and the motor nerve
innervating a group of fibers (motor unit) (reviewed in [24–26]). Development and
maintenance of slow characteristics requires low frequency, almost continuous
stimulation, typically imposed by a slow motor nerve. In contrast, development of
fast characteristics is independent of innervation, but dependent on T3 [20, 26–28].
Moreover, T3 counteracts the effect of slow innervation by stimulating the fast
phenotype. Consequently, the degree of motor nerve activity and the level of T3
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determine to which extent the slow or fast genetic programs are expressed within a
motor unit, although intrinsic properties of individual fibers may limit the range of
phenotypic changes induced by these factors [20].
The identification of the family of myogenic regulatory factors (MRF) provided
a possible mechanism for the coordinated expression of phenotype [29]. The MRF’s
initiate the muscle gene program and low levels of these transcription factors are
most likely involved in maintenance of the differentiated state. Even though con-
siderable redundancy exits between the various MRF’s, phenotype specificity was
observed with MyoD predominantly expressed in fast muscles and myogenin in slow
muscles [30, 31]. Conversion of the phenotype by denervation, cross-innervation, and
to some extent by T3 , was usually accompanied by an appropriate change in the
relative expression of MyoD and myogenin [30, 32, 33]. However, a strict correlation
between fiber type and expression of a particular MRF was not supported by further
analysis, and additional factors are probably involved [34–36]. Notably, the fast-to-
slow phenotypic changes induced by electrical stimulation preceded the change in
MRF expression by several days [37], supporting the suggested role of MRF’s in
consolidating a specific phenotype, rather than being a primary regulator.
Irrespective of the underlying mechanism, the dynamic balance between inner-
vation and T3 illustrates the characteristic plasticity of skeletal muscle which allows
(adaptive) changes in response to altered workload or thyroid status. So, depending
on the type of muscle, increasing levels of T3 induce a consecutive shift from MHC
I to IIa, to IIx, to IIb, inducing one gene, while turning off the other [21]. The
most prominent shift in contractile properties seen in slow muscle from hypo- to
hyperthyroidism (MHC I to IIa), is in keeping with the large increase in SR Ca2+-
ATPase activity in slow muscle described above. Because T3 does not increase the
amount of force generated, the effects on Ca2+-cycling and cross-bridge cycling result
in an energetically less efficient force production and a greater dissipation of heat
during contraction [19, 38–40].
Summarizing, these data showed that T3 enhances the Ca
2+-cycling capacity of
skeletal muscle through increased expression of the SR Ca2+-ATPase, thereby speed-
ing-up the contraction-relaxation cycle at an increased energy cost. This applies to
fast and slow muscle in the transition from hypo- to euthyroidism, but mainly to
slow skeletal muscle in the transition to hyperthyroidism.
T3 AND EXPRESSION OF Ca
2+-ATPase ISOFORMS
Three genes, SERCA1, 2 and 3 encode a total of five isoforms of the sarco-
plasmicendoplasmic reticulum Ca2+-ATPase (reviewed in Ref. 41). SERCA1 and
SERCA2a are the SR Ca2+-ATPases expressed in adult muscle. SERCA1 is predomi-
nantly expressed in fast muscle and SERCA2a in slow muscle. The heart expresses
exclusively SERCA2a, and SERCA1 cannot be induced in this tissue under any
condition. Unlike the MHC isoforms there are few, if any, intrinsic differences
between both SERCA isoforms [42]. The difference lies in the maximal expression
levels that can be attained for both genes. Under normal conditions fast muscles
express 5 to 7-times higher levels of SERCA1 compared to the level of SERCA2a
in slow muscles [16, 17, 41, 43–46]. This muscle-specific expression suggested that
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SERCA1 and SERCA2a are reciprocally regulated by T3 , similar to the fast and
slow MHC isoforms, as part of a slow or fast genetic program.
Analysis of SERCA mRNA, -protein and Ca2+-ATPase activity in slow and
fast muscle indicated that the effect of T3 is more complex and highly fiber-specific
[44, 45, 47]. Figure 1 shows the effect of the thyroid status on the total SR Ca2+-
ATPase activity in homogenates of the slow soleus muscle (SOL) and the fast exten-
sor digitorum longus (EDL) (note that the absolute activity level in euthyroid EDL is
6-times higher than that in SOL, see legend). The EDL expressed almost exclusively
SERCA1 and the T3-independent increase in Ca
2+-ATPase activity from hypothy-
roidism to euthyroidism correlated with a 50% rise in SERCA1 mRNA and protein
[44, 45, 47]. Analysis of SERCA isoform expression in the SOL indicated that T3
strongly stimulates the expression of SERCA1, with only marginal effects on
SERCA2a expression (Fig. 2) [44, 45, 47]. Figure 3 shows the stimulation by T3 of
SERCA1 expression in individual fibers of the SOL, and illustrates the large increase
in SR Ca2+-ATPase activity in the transition to hyperthyroidism. Although overall
SERCA2a expression seemed unaffected by T3 , differential effects became evident
when expression was analyzed at the level of individual fibers [47]. As shown in Fig.
4, SERCA2a was expressed in all fibers in the hypothyroid SOL and co-expressed
with MHC I in 85% of them, those being the slow type I fibers. In the transition to
hyperthyroidism, expression of MHC I and SERCA2a was shut off in half of the
type I fibers, implying that the level of SERCA2a expression in the remaining fibers
increased, since total SERCA2 mRNA and protein levels were only marginally lower
[44, 45, 47]. SERCA1 and MHC II (fast) isoforms were cordinately induced in SOL
Fig. 1. SR Ca2C-ATPase activities in homogenates of SOL and EDL
muscles of hypothyroid (filled columns) and hyperthyroid rats (2 weeks of
T3 treatment) (open columns), expressed relative to euthyroid activity levels
(100%, shaded columns) (meanJSD, nG5). Absolute activities in euthyroid
preparations: SOL: 13.5J2.9 [5]; EDL: 79J7 [5] (µmolg wet weight · min
at 25°C). Effects of hyper- and hypothyroidism relative to euthyroid control
were significant ( pF0.05), except for hyperthyroidism in EDL. Data from
Ref. 45.
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Fig. 2. Total SERCA1 and SERCA2a protein (panel A) and mRNA (panel B) content of SOL
muscle from hypo- (HYPO), euthyroid (EU), and euthyroid rats treated with T3 for 2 weeks
(HYPER) (nG2, meanJSD). Total SERCA protein or mRNA content of the euthyroid SOL
was set to 100%, and HYPO and HYPER values were expressed relative to the EU expression
levels (from Ref. (7). These data confirmed earlier extensive analyses of mRNA [45] and
SERCA protein [44]. Reproduced with permission from The American Physiological Society:
Am. J. Physiol. 271 (Cell Physiol. 40) C1908–C1919, (1996).
Fig. 3. Immunofluorescent and histochemical stainings of serial cross-sections of SOL
muscle from hypo- (HYPO), euthyroid (EU), and euthyroid rats treated with T3 for 2
weeks (HYPER). SERCA1 was detected with an isoform-specific antibody, and these
fibers stain light. SR CA2C-ATPase activity was visualized as described in Ref. 89, and
fibers with high SR Ca2C-ATPase activity stain dark (from Ref. 47). Bar: 0.25 mm. Repro-
duced with permission from The American Physiological Society: Am. J. Physiol 271 (Cell
Physiol. 40) C1908–C1919 (1996).
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Fig. 4. Immunofluorescent stainings of serial cross-sections of SOL muscle from hypo-
(HYPO), euthyroid (EU) and euthyroid rats treated with T3 for 2 weeks (HYPER).
Monoclonal antibodies for SERCA1, MHC I and MHC II, and a polyclonal serum for
SERCA2a were used. Fibers binding the antibodies stain light. Type I fibers are positive
with the MHC I, and negative with the MHC II antibody (85% of the fibers in HYPO).
Type IIA fibers stain with MHC II antibody and are negative with the MHC I antibody
(examples indicated by arrow heads), and type IIC fibers stain with both MHC anti-
bodies (examples indicated by arrows) (from Ref. 47). Reproduced with permission
from The American Physiological Society: Am. J. Physiol. 271 (Cell Physiol. 40) C1908–
C1919 (1996).
from 13% of the fiber population in hypothyroidism to 20% in euthyroidism and
100% in hyperthyroid muscle. The levels of SERCA1 mRNA and protein were
further increased by T3 in fibers that already expressed SERCA1. In the hyper-
thyroid SOL the Ca2+-ATPase activity was highest in the fibers expressing solely
SERCA1 and MHC II isoforms [47]. In other words, T3 induces a coordinated
switch of MHC and SERCA isoforms in practically all fibers of the SOL; approxi-
mately half of them are converted from a slow to a fast phenotype (IIA), the other
half being converted to a mixed slowfast phenotype (type IIC).
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The full conversion of only half of the SOL fibers probably reflects intrinsic
differences between fiber populations, since the range of activities of the slow motor
units in SOL is small (see Ref. 47 for a detailed discussion). The mechanism for the
down-regulation of SERCA2a in fibers that do convert completely to the fast pheno-
type remains unclear. However, we noted that inhibition of SERCA2a expression
occurred at a pre-translational level, and only after fibers had attained high relative
SERCA1 expression levels and concomitant SR Ca2+-ATPase activities [47]. This led
us to suggest that changes in intracellular [Ca2+], as a consequence of T3-induced
changes in SR Ca2+-uptake activity, may differentially affect expression of SERCA
isoforms (see section on Ca2+-dependency below).
In the fast EDL muscle SERCA1 was the major isoform detected, with only
low levels of SERCA2a mRNA and protein corresponding to a small population of
type I fibers (<3%) [47]. The T3-response of these fibers was the same as seen for
type I fibers in SOL. The expression level of SERCA1 mRNA in the type II fibers
was only modestly affected by the thyroid status, which correlated with a 1.5-fold
change in SERCA1 protein content and SR Ca2+-ATPase activity in the transition
from hypothyroidism to hyperthyroidism (see also Fig. 1). The limited responsive-
ness of SERCA1 in adult fast muscle contrasts with the effect of T3 in neonatal
muscle development. Earlier we had shown that the large increase in SR Ca2+-
ATPase activity in neonatal fast muscle is absolutely dependent on the rise in serum
T3 , which starts in the first week of life [28]. Subsequent analysis showed that T3
induced a 6-fold increase in SERCA1 mRNA [48]. This is a direct T3 effect and not
secondary to stimulation of growth hormone or insulin like growth factor I (IGF-
I), which are both involved in muscle growth and differentiation [28].
Summarizing, these results indicated that the regulation of both isoforms of SR
Ca2+-ATPase by T3 is established primarily at a pre-translational level and generally
coordinated with expression of MHC isoforms. Furthermore, the SERCA1 gene is
a principle target of T3 and high levels of SR Ca
2+-ATPase activity, as in fast muscle
and the hyperthyroid SOL, can only be attained by expression of SERCA1. Taken
together with studies showing the repression of the fast gene program by slow type
innervation [24], the data illustrate the dynamic equilibrium between T3 and contrac-
tile activity in determining the phenotype and SR Ca2+-ATPase activity, with
SERCA1 being the pivotal player.
MECHANISM OF T3-REGULATED EXPRESSION OF SERCA1
Skeletal muscle cell lines were used to analyze the regulation of SERCA1
expression by T3 in more detail. IGF-I was initially included in these analyses
because it is regulated by T3 and involved in skeletal muscle differentiation (cf. [49]).
T3 stimulated the expression of SERCA1 mRNA and functional protein in L6
myotubes, and the effect was potentiated in the presence of IGF-I [49]. IGF-I alone
had little effect, but in the presence of T3 it doubled the half-life of both SERCA1
mRNA and protein. The principle action of T3 was a 3-fold stimulation of the
transcription rate of the SERCA1 gene as determined by nuclear run-on analysis.
This mode of action of T3 is in agreement with the generally accepted view that
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nuclear T3-receptors (TR) mediate the effect of the hormone on gene expression
[50, 51].
The three known TR isoforms are encoded by two genes, c-erbAα and c-erbAβ .
They belong to a family of ligand-dependent transcription factors which bind to cis-
regulatory DNA sequences in the promoters of target genes, allowing hormone-
dependent modulation of transcription rates [50, 51]. In the case of T3 these cis-
elements are termed thyroid hormone response elements (TRE) [52]. The optimal
binding site for a single TR has the consensus sequence AGGTCA. A TRE typically
consist of two to four TR binding sites, oriented as direct repeats (head to tail )
spaced by 4 nucleotides, or as everted repeats (tail to tail ) spaced by 6 nucleotides,
or as inverted repeats with no spacing (palindrome). This organization allows for
cooperative receptor binding and dimerization or multimerization, which positively
correlates with transactivation. TR binding and transactivation is increased by
heterodimerization with the ubiquitous retinoid X receptor (RXR), a member of the
TR-receptor family. It recognizes the same DNA binding motif, and is considered
the natural partner for TRs in ûiûo. Deviations from the optimal binding-site
sequence and, to a lesser extent, from the optimal spacing between them, are com-
mon in naturally occurring TRE’s and responsible for large differences in TR-bind-
ing affinity and transactivation potency. A promoter may contain several TRE’s
contributing to the overall T3-respectiveness. In contrast to other members of the
nuclear receptor family, TRs bind to their response elements in the unliganded state,
resulting in a substantial repression of promoter activity. Binding of T3 to the TR
relieves this repression and induces an interaction with the transcription initiation
complex, stimulating transcriptional activity. T3-induced transactivation is therefore
the result of two separate phenomena, relief of repression and true activation. Both
processes are now known to involve numerous proteins forming large coactivator or
corepressor complexes, that act as adapters between receptors and the transcription
initiation complex (reviewed in Ref. 53). Recent analyses of TR knock-out mice
indicate considerable redundancy in isoform function, although some aspects of T3
action are isoform specific [54–56]. For instance, TRβ is required for the develop-
ment of hearing and the feed-back regulation of thyroid hormone production,
whereas the absence of TRα results in a reduced heart rate and slightly lower body
temperature. Mice lacking both TR genes are viable and, surprisingly, they show a
much less pronounced reduction of body temperature than observed in hypothyroid
neonatal rats, which die within 6 weeks [28, 54, 55, 57]. This is most likely explained
by the active repression of T3-responsive genes in hypothyroidism by the unliganded
receptor, which does not occur in TR-deficient animals.
Skeletal muscle expresses the two principle receptor isoforms TRα1 and TRβ1,
as well at TRα2. The latter isoform is not a true T3-receptor since it cannot bind
T3 , but because the domains for DNA-binding and dimerization are conserved, it
can act as a dominant negative regulator of T3-responsive genes. Its proper physio-
logical function is not known. Although data on the expression of TR-isoform
mRNAs indicate no differences between fast and slow muscle, species differences
may exist in the relative levels of TRα1 and TRβ1 [58, 59]. Immunohistochemical
analyses indicated similar levels of TRα1 and TRβ1 protein in slow and fast muscle
in the rat [60]. These data do not suggest a muscle-type specific role of TR isoforms,
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which is supported by a recent analysis of MHC-isoform expression in SOL and
EDL in TR knock-out mice [61]. This study did, however, indicate that both TRα
and TRβ isoforms are required for the full effect of T3 on slow muscle.
To analyze the T3-regulated expression of SERCA1 in detail we cloned the 5′-
flanking sequence of the SERCA1 gene of the rat. Analysis of the first 962 base pairs
(bp) of this promoter in COS (kidney) cells confirmed the T3-responsiveness of the
gene [62]. T3-induced a TR-dependent, 4-fold increase of the transcription rate which
was doubled in the presence of RXR. TRα1 and TRβ1 were equally potent in
repressing transcription and mediating stimulation by T3 . Three sequences were
identified that met the criteria for a TRE, i.e., they bound TR with high affinity
(dimers and oligomers), and conferred T3-responsiveness when inserted in a hetero-
logous promoter (thymidine kinase, TK). The TRE at position A545 (R3) bound
TR with the highest affinity and also conferred the highest T3-induction ratio to
the TK promoter (6-fold). Detailed analysis showed that it consisted of an unusual
combination of 4 half sites. The SERCA1 sequence also contained several binding
sites for MRFs so called ‘‘E-boxes’’ (CANNTG) [29]. Comparison of the SERCA1
promoter with the published sequence of the SERCA2 promoter showed no simi-
larities. However, multiple TREs were also found to be responsible for T3-respon-
siveness of this gene [63, 64].
Analyses of the 962 bp SERCA1 promoter in L6 muscle cells showed only a 2-
fold T3-induction, but this increased to 5-fold when an extended promoter fragment
(2658 bp) was used [65]. This long promoter generated a 20-fold higher transcrip-
tional activity in L6 than in COS cells, indicating the effect of tissue specific factors
(Simonides and Thelen, unpublished results). Recently we identified a strong TRE
at positionA1710 (R) responsible for the extra T3-induction in L6 cells. In conferred
an 8-fold T3-induction to the TK-promoter and site-directed mutagenesis indicated
a half-site organization similar to other potent TREs. Figure 5 gives the sequences
and TR-binding sites of TRE R3 and R5, and the deletion analysis of the SERCA1
promoter in L6 myoblasts which indicated the position of these elements. We now
conclude that TRE R5, together with TRE R3, confer T3-responsiveness to the
SERCA1 gene in muscle cells (Simonides and Thelen, unpublished results).
Ca2C-DEPENDENCY OF T3-REGULATED SERCA1 EXPRESSION
The average intracellular free calcium concentration ([Ca2+ ] i ) is approximately
50–100 nM in fast fibers, and 200–300 nM in slow fibers, as a result of the difference
in contractile activity (see aboûe). Several lines of evidence suggested that these dif-
ferences in [Ca2+] i may be involved in regulating gene expression [66–69]. In line
with this we found that contractions suppressed the basal expression of SERCA1 in
cultured primary myotubes at a pretranslational level. This correlated with a reduced
MyoDmyogenin mRNA ratio, but a coordinate fast-to-slow switch was not indi-
cated, since SERCA2a expression was not affected [70]. However, the effect of con-
tractions on SERCA1 expression was in line with the [Ca2+] i-dependency of
SERCA1 expression which we found earlier in non-contracting L6 myotubes [71].
In that study basal expression was optimal around 120 nM [Ca2+] i and decreased to
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Fig. 5. Progressive 5′-deletion fragments of the 2658 bp promoter of the rat SERCA1 gene were inserted
in the promoterless pOCAT2 vector and analyzed for T3-responsiveness in transient transfection assays
using L6 myoblasts. Suspected TRE sequences are indicated in the promoter. Only deletion of regions
containing R3 and R5 resulted in a significant loss of T3-stimulation of transcription. Mobility-shift
analyses and site-directed mutagenesis identified R3 and R5 as functional TREs. TR binding-sites essen-
tial for transactivation are indicated in the DNA sequences (bold face) and their orientation is indicated
by arrows (from Ref. 62 and unpublished results (Simonides and Thelen)).
about 50% at 185 nM, but, surprisingly, the 5-fold T3-stimulation of SERCA1 pro-
tein expression at 120 nM was practically abolished at 185 nM. The same effect was
found in C2C12 myotubes, when contractions were used to increase [Ca2+] i and this
was shown to result from a specific block of the 7-fold T3-stimulation of the 2658 bp
SERCA1 promoter [72]. These results suggest that the switch of fast muscles to the
slow phenotype, induced by continuous electrical stimulation [24], is at least in part
due to suppression of the stimulatory effect of T3 on fast isoforms.
Analysis in L6 cells confirmed that the effect of increasing [Ca2+] i on the T3-
dependent expression of SERCA1 protein occurs at a pre-transional level. Further-
more, it showed that this is correlated with induction of myogenin expression [65].
Figure 6 shows the Ca2+-dependent inhibition of the effect of T3 on SERCA1 mRNA
expression, as well as the strong induction of myogenin mRNA expression with
increasing [Ca2+] i . Subsequent co-transfection experiments with SERCA1 promoter
constructs and myogenin expression vetors showed that myogenin specifically blocks
the effect of T3 on SERCA1 promoter activity [65]. With respect to SERCA1
expression, these data suggest a mechanism for the opposing effects of contractile
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Fig. 6. L6 myotubes were cultured in the presence or absence of T3 , and different concentrations of
ionomycin were used to obtain the intra-cellular [Ca2C ] indicated. Total RNA was isolated at day 3 and
Northern blots were probed for SERCA1 (left panel) or myogenin mRNA (right panel). Hybridization
with an 18S rRNA oligonucleotide provided normalization. T3 had no effect on myogenin mRNA levels
(from Ref. 65). Reproduced with permission from Thelen, M. H., Simonides, W. S., Muller, A., and van
Hardeveld, C. (1998) Biochem. J. 329:(1):131–136. The Biochemical Society.
activity and T3 on the fast phenotype, with [Ca
2+] i being a driving force. It should
be noted that for any given level of motor-nerve activity, enhancement of SERCA
activity by T3 will affect the average [Ca
2+] i . It was shown recently that the [Ca
2+] i-
dependent calcineurin pathway of gene regulation may play a role in phenotypic
regulation in skeletal muscle [73]. This signaling route could provide a link between
the changes in [Ca2+ ] i—either resulting from altered contractile activity or altered
SR Ca2+-ATPase activity—and the expression of MRFs and other factors regulating
muscle gene transcription.
ROLE OF T3-REGULATED SERCA EXPRESSION IN THERMOGENESIS
The data discussed thus far show that expression of SR Ca2+-ATPase is to a
large extent dependent on direct regulation by T3 . Apart from the absolute depen-
dency during neonatal development, 30–50% of the expression in skeletal muscle of
the adult, euthyroid animal is T3-dependent. Furthermore, the net stimulation of
Ca2+-ATPase activity by higher levels of T3 , is solely the result of increased
expression of the SERCA1 isoform. The possible role of this regulation in a ther-
mogenic effect of T3 during prolonged cold exposure is discussed in the following
sections.
CONTRIBUTION OF SR CA2C-CYCLING TO THE METABOLIC RATE
DURING REST
Maintenance of Ca2+-homeostasis by the SR Ca2+-ATPase in resting muscle is
estimated to account for 10–25% of the RMR of this tissue, based on in ûitro analy-
ses of Ca2+-ATPase function in purified SR [74–76]. Maintenence of the steep Ca2+-
gradient over the SR membrane is a balance between active uptake and efflux of
Ca2+ back into the cytosol. Passive efflux through the SR membrane is low, but the
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Ca2+-ATPase can ‘‘slip’’, i.e., the optimal Ca2+ATP coupling ratio of 2 decreases to
much less than 1 as the gradient builds. This accounts for a substantial energy turn-
over at steady state [74–76]. De Meis recently showed that the SERCA1 isoform of
the Ca2+-ATPase can mediate so-called uncoupled Ca2+-efflux in which osmotic
energy is converted to heat [6, 77]. It was suggested that a variable proportion of the
SR Ca2+-ATPases may operate in this mode, determining the overall ATP turnover
and dissipation of heat during maintenance of the gradient. It is tempting to specu-
late that such variation underlies the earlier reported higher coupling ratio and 30%
lower ATP turnover associated with maintenance of a Ca2+-gradient, in hypothyroid
vs. euthyroid fast muscle SR, where all other parameters, such as Ca2+-ATPasemg SR
and passive efflux rates, were equal [74]. T3-induced changes in SR membrane lipid
composition, which correlated with slightly altered catalytic properties of the Ca2+-
ATPase [13, 78], could provide a basis for such variation. Most studies on Ca2+-
ATPase kinetics and energetics have been done with fast muscle SR and it is not known
whether SERCA2a can operate in the uncoupled efflux mode. Recently it was shown
that the SERCA2b isoform of endoplasmic reticulum in blood platelets does not
show uncoupled efflux, unless platelet activating factor is present [79]. SERCA2b is
a splice variant of the SERCA2 gene in which the 4 c-terminal amino acids present
in SERCA2a are replaced by an extended 49 or 50 amino acid sequence [80, 81].
The estimate of the energy cost of Ca2+-homeostasis at rest derived from the in
ûitro data mentioned above, is generally supported by indirect calorimetric and O2-
consumption measurements of different types of isolated or perfused, denervated
muscles, which yield an estimate between 5 and 25% of the RMR of muscle
[1, 82, 83]. Given the fact that skeletal muscle accounts for approximately 20% of
the RMR of the animal, the contribution of SR Ca2+-ATPase activity at rest to the
overall RMR is not more than 5% [1]. As a result, the T3-dependent stimulation of
SR Ca2+-ATPase activity may account for at most 10% of the increase in RMR in
the transition from hypothyroidism to hyperthyroidism. The possible contribution
of T3-dependent SR Ca
2+-cycling to NST is therefore small. However, the T3-induced
increase in SERCA1 expression will potentiate the effect of any mechanism that
selectively stimulates Ca2+-cycling. Several such mechanisms have been proposed in
which Ca2+-leakiness of the SR is increased (cf. Ref. 7), but their contribution to
NST has not yet been firmly established. An alternative hypothesis for skeletal-
muscle dependent NST, which does not involve Ca2+-cycling, suggests induction
of the mitochondrial uncoupling protein UCP3, a homologue of UCP1. Such a
mechanism has not been confirmed yet and is in fact debated [2, 84].
CONTRIBUTION OF SR Ca2C-CYCLING TO THE METABOLIC RATE
DURING ACTIVITY
As mentioned earlier, SR Ca2+-cycling accounts for up to 50% of the energy
turnover in muscle during contraction [1, 10, 11]. The overall metabolic rate during
exercise is therefore primarily determined by SR Ca2+-ATPase activity and the
ATPase activity of the contractile filaments. It should be noted that the maximal
energy consumption by SR Ca2+-ATPase alone, is 5 to 10 times higher than the
RMR of the muscle. The enormous capacity to generate heat by Ca2+-cycling in
muscle is further illustrated in malignant hyperthermia, where a defective SR
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Ca2+-release channel can be triggered to leak, leading to a lethal rise in body tem-
perature (reviewed in Ref. 7). Consequently, SR Ca2C-ATPase activity accounts for
a substantial part of the extra heat generation during shivering, with 30–50% of the
contribution being dependent on T3 in the euthyroid animal.
Primarily slow, fatigue-resistant motor units are recruited in the shivering
response during acute cold exposure [85, 86]. These motor units are already active
20–30% of the time, and even though they have a relatively low maximal capacity
for energy turnover, their increased activity apparently generates sufficient heat. It
is intriguing that these slow fibers are also the ones most responsive to increased T3-
levels. The presented data indicate that as shivering subsides and serum T3-levels
rise and NST takes over, expression of high levels of SERCA1 is induced in these
fibers, as well as faster MHC isoforms, and the phenotype gradually shifts from slow
oxidative type I, to fast oxidative type IIC or IIA. As a result, the energy turn-over
of these motor units almost doubles—at the same level of force production—but the
motor-nerve activity will not have changed, i.e., they will still be active 20–30% of
the time. Consequently, these effects on fiber phenotype, and the associated increase
in heat production at normal levels of physical activity, may provide a mechanism
for a T3-dependent thermogenic response during prolonged cold exposure. The
higher percentage of slow motor units in muscles of larger mammals is a relevant
factor for the possible importance of the mechanism we propose here. In man the
average percentage of type I fibers in all skeletal muscles is about 50%, whereas this
is 10% in, for instance, rat, guinea pig and cat, with the exception of some pure slow
muscles like the SOL [23, 87]. The capacity to generate heat through this route is
therefore substantially greater in those larger species that cannot rely on BAT for
NST. A role in facultative thermogenesis of phenotype modulation by T3 , particu-
larly with respect to SERCA1 expression, is supported by observations in cold-
acclimated ducks. Like larger mammals, ducks also need to rely on tissues other
than BAT to survive in the cold, and up to 70% of NST in these animals was found
to originate in skeletal muscle [88]. This was correlated with increased expression of
SERCA1, resulting in a 30–50% increase in SR Ca2C-ATPase activity [8, 9]. Perhaps
the ultimate adaptive use of the high levels of Ca2+-ATPase activity that can be
attained with the SERCA1 gene, is found in the modified extraocular muscles that
harness the heat generated by Ca2+-cycling to warm the brain and eyes in several
species of fish [7]. This heater-tissue has no contractile function, but instead is filled
with mitochondria and SR packed with SERCA1.
In conclusion, the T3-induced up-regulation of SERCA1 in slow muscle fibers
appears to provide a robust way to generate extra heat, at the same level of physical
activity, and we suggest that this route contributes to the thermogenic response in
those animals that need to rely on skeletal muscle for adaptation to the cold.
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